Skip to content

Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level

Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level of Leukemia patient referring to clinic of Ali-ibn-Abitaleb Hospital in Zahedan

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180425039418N4
Enrollment
60
Registered
2019-01-25
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Major depression disorders. Condition 2: Anxiety. Major depressive disorder, Recurrent, Unspecified Anxiety disorder due to known physiological condition

Interventions

Intervention 1: First intervention group: In this group, 30 patients with the definite diagnosis of leukemia with the age range of 18 to 64 years old at the clinic of Ali-ibn-Abitaleb Hospital in Zahe

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: The age range of patients is between 18 to 64 years old The patients were administered with the definite diagnosis of leukemia by the specialist All the patients should fill up the written consent and give it to the researchers for attending the study The education level of the patients is at least from elementary The patients don't have any history of other medical or psychological disorders The patients don't have any history of drug consumption except smoking

Exclusion criteria

Exclusion criteria: The patient doesn't intend to attend the study The patient has a history of allergy to Sertraline

Design outcomes

Primary

MeasureTime frame
The Scale of Questionnaire on Hamilton's Depression and Anxiety. Timepoint: At the time of beginning of therapies, 1 week after beginning the therapies , 3 weeks after beginning the therapies , and 6 weeks after beginning the therapies. Method of measurement: The Scale of Questionnaire on Hamilton's Depression and Anxiety.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirali Fani

Zahedan University of Medical Sciences

mohammad.ghenaat71@gmail.com+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026